CRVO 8-K 2026-09-28

CervoMed Inc. (CRVO) 8-K dated 2026-09-28 — accession 0001437749-26-031389. This URL is the filing, not the CRVO hub.

CervoMed Inc. (CRVO) is a biotechnology company listed on US.

CervoMed Inc. filed a 8-K on 2026-09-28. Accession 0001437749-26-031389.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CRVO revenue for 2025-12-31 was $4.0M. Net income was -$27.0M. Revenue was down 58.9% from 2024-12-31 to 2025-12-31. CRVO currently screens at market cap $28.8M.

Not investment advice. The CRVO SEC hub lists recent forms. The stock page is the research view.